Slow, continuous enzyme replacement via spinal CSF in dogs with the paediatric-onset neurodegenerative disease, MPS IIIA

Barbara King, Neil R. Marshall, Sofia Hassiotis, Paul J. Trim, Justin Tucker, Kathryn Hattersley, Marten F. Snel, Robert D. Jolly, John J. Hopwood, Kim M. Hemsley

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Intra-cerebrospinal fluid (CSF) injection of recombinant human lysosomal enzyme is a potential treatment strategy for several neurodegenerative lysosomal storage disorders including Sanfilippo syndrome (Mucopolysaccharidosis type IIIA; MPS IIIA). Here we have utilised the MPS IIIA Huntaway dog model to compare the effectiveness of the repeated intermittent bolus injection strategy being used in the trials with an alternate approach; slow, continual infusion of replacement enzyme (recombinant human sulphamidase; rhSGSH) into the spinal CSF using a SynchroMed II® pump attached to a spinal infusion cannula. The ability of each enzyme delivery strategy to ameliorate lesions in MPS IIIA brain was determined in animals treated from ∼three- to six-months of age. Controls received buffer or no treatment. Significant reductions in heparan sulphate (primary substrate) were observed in brain samples from dogs treated via either cisternal or lumbar spinal CSF bolus injection methods and also in slow intra-spinal CSF infusion-treated dogs. The extent of the reduction differed regionally. Pump-delivered rhSGSH was less effective in reducing secondary substrate (GM3 ganglioside) in deeper aspects of cerebral cortex, and although near-amelioration of microglial activation was seen in superficial (but not deep) layers of cerebral cortex in both bolus enzyme-treated groups, pump-infusion of rhSGSH had little impact on microgliosis. While continual low-dose infusion of rhSGSH into MPS IIIA dog CSF reduces disease-based lesions in brain, it was not as efficacious as repeated cisternal or spinal CSF bolus infusion of rhSGSH over the time-frame of these experiments.

Original languageEnglish
Pages (from-to)443-453
Number of pages11
JournalJOURNAL OF INHERITED METABOLIC DISEASE
Volume40
Issue number3
DOIs
Publication statusPublished - May 2017
Externally publishedYes

Keywords

  • Heparan Sulphate
  • Lysosomal Storage Disorder
  • Bolus Infusion
  • Metachromatic Leukodystrophy
  • Heterozygous Control

Fingerprint Dive into the research topics of 'Slow, continuous enzyme replacement via spinal CSF in dogs with the paediatric-onset neurodegenerative disease, MPS IIIA'. Together they form a unique fingerprint.

  • Cite this

    King, B., Marshall, N. R., Hassiotis, S., Trim, P. J., Tucker, J., Hattersley, K., Snel, M. F., Jolly, R. D., Hopwood, J. J., & Hemsley, K. M. (2017). Slow, continuous enzyme replacement via spinal CSF in dogs with the paediatric-onset neurodegenerative disease, MPS IIIA. JOURNAL OF INHERITED METABOLIC DISEASE, 40(3), 443-453. https://doi.org/10.1007/s10545-016-9994-1